Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M O Spach

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Bordeaux Medical|June 1, 1971
[Renovascular arterial hypertension]J Schwartz, M O Spach
Bordeaux Medical|June 1, 1971
[Hypotensive drugs]J Schwartz, M O Spach
Therapie|May 1, 1977
[Clinical study of various vasodilator agents by measuring the isotopic peripheral flow]M O Spach, J Schwartz
La Nouvelle Presse Medicale|December 31, 1975
[Comparison of the pA2 of various beta blocking agents]M O Spach, F Miesch, J Schwartz
La Nouvelle Presse Medicale|April 9, 1977
[Clinical and biological manifestations following the interruption of prolonged treatment with clonidine]M O Spach, C Steimer, R Bloch
La Presse Medicale|October 17, 1970
[Arterial hypertension in adults due to segmental aglomerular hypoplasia]M O Spach, J L Imbs, J Schwartz
Schweizerische Medizinische Wochenschrift|February 7, 1981
[Benoxaprofene: pharmacokinetic profile in the normal subject and patients with renal insufficiency; evaluation of anticipated serum levels]J M Brogard, B Audhuy, M O Spach
Coeur Et Medecine Interne|April 1, 1973
[Malignant nephroangiosclerosis. Development and treatment]M O Spach, J L Imbs, J Schwartz
Contributions to Nephrology|January 1, 1984
Nephrotoxicity of aminoglycosides. Effects on pharmacokinetics and preventionJ M Brogard, F Comte, M O Spach
La Nouvelle Presse Medicale|September 16, 1972
[Malignant nephroangiosclerosis. Development and treatment]M O Spach, J L Imbs, J Schwartz
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Bordeaux Medical|June 1, 1971
[Renovascular arterial hypertension]J Schwartz, M O Spach
Bordeaux Medical|June 1, 1971
[Hypotensive drugs]J Schwartz, M O Spach
Therapie|May 1, 1977
[Clinical study of various vasodilator agents by measuring the isotopic peripheral flow]M O Spach, J Schwartz
La Nouvelle Presse Medicale|December 31, 1975
[Comparison of the pA2 of various beta blocking agents]M O Spach, F Miesch, J Schwartz
La Nouvelle Presse Medicale|April 9, 1977
[Clinical and biological manifestations following the interruption of prolonged treatment with clonidine]M O Spach, C Steimer, R Bloch
La Presse Medicale|October 17, 1970
[Arterial hypertension in adults due to segmental aglomerular hypoplasia]M O Spach, J L Imbs, J Schwartz
Schweizerische Medizinische Wochenschrift|February 7, 1981
[Benoxaprofene: pharmacokinetic profile in the normal subject and patients with renal insufficiency; evaluation of anticipated serum levels]J M Brogard, B Audhuy, M O Spach
Coeur Et Medecine Interne|April 1, 1973
[Malignant nephroangiosclerosis. Development and treatment]M O Spach, J L Imbs, J Schwartz
Contributions to Nephrology|January 1, 1984
Nephrotoxicity of aminoglycosides. Effects on pharmacokinetics and preventionJ M Brogard, F Comte, M O Spach
La Nouvelle Presse Medicale|September 16, 1972
[Malignant nephroangiosclerosis. Development and treatment]M O Spach, J L Imbs, J Schwartz
Pageof 4